Wellinks Raises $10 Million in Series B Funding
Wellinks, a company specializing in personalized, virtual pulmonary rehabilitation programs, has successfully closed a $10 million Series B funding round. The investment comes as Wellinks continues to develop and expand its innovative approach to improving lung health, particularly for individuals with Chronic Obstructive Pulmonary Disease (COPD).
Funding Details
The Series B round, announced on August 3, 2026, was led by UMass Memorial Health. Inside Investors also participated in this round, underscoring the ongoing support and confidence in Wellinks' mission to transform respiratory care.
Leadership and Vision
Jennifer Barretta, CEO of Wellinks, is at the forefront of these efforts. Under her leadership, the company aims to redefine how respiratory care is delivered by integrating virtual chronic disease management with remote patient monitoring.
Strategic Use of Funds
The newly secured funds will primarily support Wellinks' commercial growth. The company plans to enhance its predictive care solutions, which utilize proprietary, FDA-cleared technology for remote patient monitoring. Wellinks’ Health Tags provide passive, continuous monitoring that can predict clinical deterioration up to a week before symptoms arise, allowing for proactive clinical intervention. This approach aims to reduce acute care utilization, lower readmission rates, and decrease overall healthcare costs.
Location and Expansion
Based in New Haven, Connecticut, Wellinks is positioned to expand its reach and impact within the healthcare sector. The investment will facilitate the acceleration of its predictive care solutions, further closing care gaps for the traditionally underserved population with respiratory issues.
Conclusion
This latest funding round marks a significant milestone for Wellinks as it continues to innovate and improve the delivery of respiratory care. With the backing of notable investors like UMass Memorial Health, Wellinks is set to enhance its virtual care offerings, benefiting patients and healthcare providers alike.